期刊文献+

E-cadherin在乳腺癌中的表达及其临床意义 被引量:2

E-cadherin Expression in Breast Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的 :研究上皮钙黏附素 (epithelialialcadherin ,E cadherin)表达与乳腺癌生物学行为的关系及对预后的意义。方法 :采用免疫组织化学方法检测 5 1例乳腺浸润性导管癌组织E cadherin表达水平 ,并对其与乳腺癌临床病理特征和术后生存时间的关系进行统计学分析。结果 :本组 5 1例中E cadherin高表达者 2 1例 ,占 4 1 2 % ;低表达者 30例 ,占 5 8 8%。E cadherin表达水平与肿块大小、腋淋巴结状态、TNM分期、组织学分级、复发和转移相关 ;单因素生存分析提示E cadherin高表达组术后 5年生存率高于低表达组 ;Cox比例风险模型多因素分析显示E cadherin表达水平是乳腺癌的独立预后指标。结论 :E cadherin表达下调促进肿瘤恶性进展 ,可作为乳腺癌失分化和强侵袭性行为的指标。E Objective To investigate the expression of E cadherin in breast carcinoma in relation to biological behavior and prognosis.Methods Expression of E cadherin protein was detected by immunohistochemical technique in 51 breast invasive ductal carcinoma specimens.The relationship of E cadherin expression to clinicopathological characteristics and postoperative survival time was statistically analysed.Results Of the 51 cases,the high and low E cadherin expressive rate was 41 2% (21/51) and 58 8% (30/51) respectively.E cadherin expression level was correlated with tumor size,axillary lymph node status,TNM stage,histological grade,local recurrence and distant metastasis.Univariate survival analysis demonstrated that patients with high E cadherin expression showed better postoperative 5 year survival.Cox multivariate analysis showed that E cadherin expression level was an independent prognostic marker.Conclusions Reduced E cadherin expres sion in breast carcinoma promotes malignant progression,and indicates dedifferentiation and intensive invasive biological behavior.E cadherin expression level is an independent prognostic factor in breast carcinoma.
出处 《肿瘤防治杂志》 2002年第4期356-358,共3页 China Journal of Cancer Prevention and Treatment
关键词 乳腺癌 表达 E-CADHERIN 代谢 钙黏着糖蛋白类 免疫组织化学 上皮 breast neoplasms/pathology breast neoplasms/metabolism cadherins/metabolism immunohistochemistry epithelium
  • 相关文献

参考文献7

  • 1Tamura S.The E-cadherin-mediated cell-cell adhesion system in human cancers[].British Journal of Surgery.1997
  • 2St Croix B,Sheehan C,Rak JW,et al.E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor P27Kipl[].The Journal of Cell Biology.1998
  • 3Sasaki CY,Lin HC,Passaniti A.Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis[].International Journal of Cancer.2000
  • 4Eidelman S,Damsky CH,Wheelock MJ,et al.Expression of the cellcell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors[].American Journal of Pathology.1989
  • 5Semb H,Christofori G.Insights from model systems: the tumor-suppessor function of E-cadherin[].The American Journal of Human Genetics.1998
  • 6Guriec N,Marcellin L,Gairard B,et al.E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival[].Invasion Metastasis.1996
  • 7Siitonen SM,Kononen,JT,Helin HJ,et al.Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer[].American Journal of Clinical Pathology.1996

同被引文献30

  • 1刘喜波,孟春琴.E-cadherin在乳腺癌中的表达及意义[J].重庆医学,2005,34(3):429-431. 被引量:4
  • 2吴强.c-erbB-2(HER-2/neu)与乳腺癌[J].临床与实验病理学杂志,2005,21(1):6-9. 被引量:16
  • 3陈玲,李旭,赵新汉.乳腺癌ER,PR,c-erbB-2表达与临床病理特征的相关性分析[J].第四军医大学学报,2006,27(17):1580-1583. 被引量:11
  • 4杨洁,韩为东,赵亚力.雌激素与乳腺癌[J].现代肿瘤医学,2007,15(3):431-433. 被引量:22
  • 5Elston C W,Ellis I O.Pathological prognostic factors in breast cancer I.The value of histological grade in breast cancer:experience from a large study with long-term follow-up[J].Histopathology,1991,19(5):403-10.
  • 6Robbins P,Pinder S,De Klerk N,et al.Histological grading of breast carcinomas:a study of interobserver agreement[J].Hum Pathol,1995,26(8):873-9.
  • 7Edge S B,Byrd D R,Compton C C,et al.AJCC Cancer Staging Manual[M].7th ed.New York:Springer,2010:347-76.
  • 8Tavassoli F A,Devilee P.WHO乳腺肿瘤组织学分类[M]∥乳腺及女性生殖器官肿瘤病理学和遗传学.北京:人民卫生出版社,2006:2-3.
  • 9Wolff A C,Hammond M E,Schwartz J N,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].J Clin Oncol,2007,25(1):118-45.
  • 10Slamon D J,Clark G M,Wong S G,et al.Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene[J].Science,1987,235(4785):177-82.

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部